SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001062993-16-007348
Filing Date
2016-01-29
Accepted
2016-01-29 09:33:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G/A sch13ga.htm SC 13G/A 28184
  Complete submission text file 0001062993-16-007348.txt   29416
Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G/A | Act: 34 | File No.: 005-88719 | Film No.: 161371171
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 EAST WISCONSIN AVE. STE. 303B LAKE FOREST IL 60045
Business Address
Stebbins James Henry DeGraff (Filed by) CIK: 0001634477 (see all company filings)

Type: SC 13G/A